Full Text of SB3109 98th General Assembly
SB3109 98TH GENERAL ASSEMBLY |
| | 98TH GENERAL ASSEMBLY
State of Illinois
2013 and 2014 SB3109 Introduced 2/7/2014, by Sen. Pat McGuire SYNOPSIS AS INTRODUCED: |
| |
Amends the Illinois Optometric Practice Act of 1987. Permits a licensed optometrist to prescribe Dihydrocodeinone (Hydrocodone) with one or more active, non-narcotic ingredients only in a quantity sufficient to provide treatment for up to 72 hours, and only if such formulations are reclassified as Schedule II by the U.S. Food and Drug Administration.
|
| |
| | A BILL FOR |
|
| | | SB3109 | | LRB098 18318 ZMM 53453 b |
|
| 1 | | AN ACT concerning regulation.
| 2 | | Be it enacted by the People of the State of Illinois,
| 3 | | represented in the General Assembly:
| 4 | | Section 2. The Illinois Optometric Practice Act of 1987 is | 5 | | amended by changing Section 15.1 as follows:
| 6 | | (225 ILCS 80/15.1)
| 7 | | (Section scheduled to be repealed on January 1, 2017)
| 8 | | Sec. 15.1. Diagnostic and therapeutic authority.
| 9 | | (a) For purposes of the Act, "ocular pharmaceutical
agents" | 10 | | means topical anesthetics, topical mydriatics, topical
| 11 | | cycloplegics, topical miotics and mydriatic reversing agents, | 12 | | anti-infective agents,
anti-allergy agents,
anti-glaucoma | 13 | | agents (except oral carbonic anhydrase inhibitors, which may be | 14 | | prescribed only in a quantity sufficient to provide treatment | 15 | | for up to 72 hours),
anti-inflammatory agents (except oral | 16 | | steroids), over-the-counter agents, analgesic
agents, anti-dry | 17 | | eye agents, and agents for the treatment of hypotrichosis. | 18 | | (a-3) In addition to ocular pharmaceutical agents that fall | 19 | | within the categories set forth in subsection (a) of this | 20 | | Section, the Board may add a pharmaceutical agent approved by | 21 | | the FDA or class of agents for the purpose of the diagnosis or | 22 | | treatment of conditions of the eye and adnexa after | 23 | | consideration of the agent's systemic effects, side effects, |
| | | SB3109 | - 2 - | LRB098 18318 ZMM 53453 b |
|
| 1 | | and the use of the agent within the practice of optometry. The | 2 | | Board shall consider requests for additional agents and make | 3 | | recommendations within 90 days after the receipt of the | 4 | | request. | 5 | | Within 45 days after the Board's recommendation to the | 6 | | Department of a pharmaceutical agent or class of agents, the | 7 | | Department shall promulgate rules necessary to allow for the | 8 | | prescribing or administering of the pharmaceutical agent or | 9 | | class of agents under this Act. | 10 | | (a-5) Ocular pharmaceutical agents administered by | 11 | | injection may be used only for the treatment of anaphylaxis. | 12 | | (a-10) Oral pharmaceutical agents may be prescribed for a | 13 | | child under 5 years of age only in consultation with a | 14 | | physician licensed to practice medicine in all its branches. | 15 | | (a-15) The authority to prescribe a Schedule III, IV, or V | 16 | | controlled substance shall include only analgesic agents only | 17 | | in a quantity sufficient to provide treatment for up to 72 | 18 | | hours. The prescription of a Schedule II controlled substance | 19 | | is prohibited , except for Dihydrocodeinone (Hydrocodone) with | 20 | | one or more active, non-narcotic ingredients only in a quantity | 21 | | sufficient to provide treatment for up to 72 hours, and only if | 22 | | such formulations of Dihydrocodeinone are reclassified as | 23 | | Schedule II by the U.S. Food and Drug Administration .
| 24 | | (b) A licensed optometrist may remove superficial foreign | 25 | | bodies from the human eye and adnexa and may give orders for | 26 | | patient care to a nurse licensed to practice under Illinois |
| | | SB3109 | - 3 - | LRB098 18318 ZMM 53453 b |
|
| 1 | | law.
| 2 | | (c) An optometrist's license shall be revoked or suspended | 3 | | by the Department
upon recommendation of the Board based upon | 4 | | either of the
following causes: | 5 | | (1) grave or repeated misuse of any ocular
| 6 | | pharmaceutical agent; and | 7 | | (2) the use of any agent or procedure in the course of | 8 | | optometric practice
by an optometrist not properly | 9 | | authorized under this Act. | 10 | | (d) The Secretary of Financial and Professional Regulation | 11 | | shall notify
the Director of Public Health as to the categories | 12 | | of ocular
pharmaceutical agents permitted for use by an | 13 | | optometrist. The Director of Public Health shall in turn
notify | 14 | | every licensed pharmacist in the State of the categories of | 15 | | ocular
pharmaceutical agents that can be utilized and | 16 | | prescribed by an optometrist.
| 17 | | (Source: P.A. 97-170, eff. 7-22-11.)
|
|